STRATA MEDICAL INNOVATIONS
PharmaSTRATA MEDICAL INNOVATIONS is a pharmaceutical company with 1 FDA-approved products.
STRATA MEDICAL INNOVATIONS's Key Drugs
STRATA MEDICAL INNOVATIONS's core commercial portfolio centers on NITROUS OXIDE, USP — its most strategically important drugs approved in the last 15 years.
STRATA MEDICAL INNOVATIONS's Recent FDA Approvals
New NDA/BLA approvals for STRATA MEDICAL INNOVATIONS over the last two years — novel drugs only, excluding generics and label supplements.
STRATA MEDICAL INNOVATIONS's Therapeutic Areas
Disease areas where STRATA MEDICAL INNOVATIONS has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
STRATA MEDICAL INNOVATIONS Pipeline Snapshot
Active clinical trials for STRATA MEDICAL INNOVATIONS across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • NITROUS OXIDE, USP leads revenue
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2014-11-25
- Latest
- 2014-11-25
- Applications
- 1